ADVFN US – Market Content Editor

Connect Biopharma reported a statistically significant improvement in lung function in its Phase 2 Seabreeze STAT asthma trial, while a 66% reduction in treatment failures did not reach statistical significance. Key Investor Takeaways Why CNTB Stock Is in Focus Connect Biopharma reported preliminary topline data from its 160-patient Phase 2 Seabreeze STAT Asthma study evaluating…

Cheetah Net agreed to acquire JoyPak Supply for $788,000 in cash, adding consumer, beauty and personal care products as the company continues to diversify beyond logistics and industrial equipment trading. Key Investor Takeaways Why CMCM Stock Is in Focus Cheetah Net has signed a Membership Interest Purchase Agreement to acquire all of JoyPak Supply for…

Vera Bradley reported second-quarter fiscal 2027 revenue growth of 1.1%, while stronger direct-channel sales and a tariff refund helped the company swing from an operating loss to a profit. Key Investor Takeaways Why VRA Stock Is in Focus Vera Bradley’s Q2 results showed further improvement in its direct-to-consumer business, helping offset a substantial contraction in…

A decision modeling study found that TissueCypher-guided care could increase appropriate treatment decisions for Barrett’s esophagus patients, including earlier escalation for non-dysplastic patients who later progress to high-grade dysplasia or cancer. Key Investor Takeaways Why CSTL Stock Is in Focus Castle Biosciences announced a decision modeling study evaluating whether its TissueCypher Barrett’s Esophagus test could…

SU Group secured exclusive Hong Kong and Macau distribution rights for HDX’s TRACELINE PX3 portable X-ray system, marking its second international distribution agreement of 2026 and extending its product portfolio into industrial inspection applications. Key Investor Takeaways Why SUGP Stock Is in Focus SU Group has secured exclusive distribution rights in Hong Kong and Macau…

F5 added agentic AI protections and new device intelligence capabilities to Distributed Cloud Bot Defense, extending its security controls as autonomous AI agents increase interactions with websites, applications and APIs. Key Investor Takeaways Why FFIV Stock Is in Focus F5 has introduced agentic AI detection alongside device intelligence enhancements for its Distributed Cloud Bot Defense…

Teradyne is establishing a permanent semiconductor-focused presence in India as the country expands domestic fabrication, packaging and testing infrastructure. Key Investor Takeaways Why TER Stock Is in Focus Teradyne has opened a Bengaluru office dedicated to supporting India’s developing semiconductor manufacturing industry, formalizing the automated test equipment company’s presence in the country. Located at Bagmane…

IonQ received four Best Paper Awards ahead of IEEE Quantum Week 2026, highlighting research with commercial and institutional partners across artificial intelligence, engineering and life sciences. Key Investor Takeaways Why IONQ Stock Is in Focus IonQ received four of the 27 Best Paper honors awarded ahead of IEEE Quantum Week 2026, with the company’s research…

American Fusion says its latest pulsed magnetic-field experiments produced hotter and denser plasma while maintaining toroidal stability, but quantitative measurements and independent validation remain future steps. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion reported new Texatron testing results from experiments using high-voltage capacitor banks to generate short, high-intensity magnetic-field pulses that…

Rocket Pharmaceuticals (NASDAQ:RCKT) shares rose 8% on Tuesday after the company said it reached alignment with the US Food and Drug Administration on the pivotal Phase 2 trial of RP-A501 for Danon disease. The FDA confirmed a pivotal efficacy population of 12 patients, including the first three patients treated under the study’s modified protocol, according…